Status:
UNKNOWN
The Impact of Epigenetic MMRd in Endometrial carcinomas-a Real World Study
Lead Sponsor:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Conditions:
Endometrial Neoplasms
Eligibility:
FEMALE
Brief Summary
In recent years, the incidence of endometrial carcinoma (EC) has increased significantly and patients tends to be younger. In addition to known risk factors such as obesity, hypertension and diabetes,...
Detailed Description
We conducted a retrospective real-world study of all endometrial carcinoma cases from 2019 to 2022. The inclusion criterion is all patients diagnosed with endometrial cancer in our hospital from 2019 ...
Eligibility Criteria
Inclusion
- all patients diagnosed with endometrial cancer in our hospital from 2019 to 2022
Exclusion
- those without histological specimens in our hospital
Key Trial Info
Start Date :
November 17 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2024
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT05334303
Start Date
November 17 2022
End Date
May 1 2024
Last Update
November 21 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.